High-throughput assays for promiscuous inhibitors

被引:271
作者
Feng, BY
Shelat, A
Doman, TN
Guy, RK
Shoichet, BK
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Grad Grp Chem & Chem Biol, San Francisco, CA 94143 USA
[3] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA
关键词
D O I
10.1038/nchembio718
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High-throughput screening (HTS) searches large libraries of chemical compounds for those that can modulate the activity of a particular biological target; it is the dominant technique used in early-stage drug discovery. A key problem in HTS is the prevalence of nonspecific or 'promiscuous' inhibitors. These molecules have peculiar properties, act on unrelated targets and can dominate the results from screening campaigns(1). Several explanations have been proposed to account for promiscuous inhibitors, including chemical reactivity(1,2), interference in assay read-out(2), high molecular flexibility(3) and hydrophobicity(2,4). The diversity of these models reflects the apparently unrelated molecules whose behaviors they seek to explain. However, a single mechanism may explain the effects of many promiscuous inhibitors: some organic molecules form large colloid-like aggregates that sequester and thereby inhibit enzymes(5). Hits from HTS, leads for drug discovery and even several drugs appear to act through this mechanism at micromolar concentrations(5-9). Here, we report two rapid assays for detecting promiscuous aggregates that we tested against 1,030 'drug-like' molecules. The results from these assays were used to test two preliminary computational models of this phenomenon and as benchmarks to develop new models.
引用
收藏
页码:146 / 148
页数:3
相关论文
共 14 条
[1]   Random forests [J].
Breiman, L .
MACHINE LEARNING, 2001, 45 (01) :5-32
[2]   Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability [J].
Frenkel, YV ;
Clark, AD ;
Das, K ;
Wang, YH ;
Lewi, PJ ;
Janssen, PAJ ;
Arnold, E .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) :1974-1983
[3]   A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases [J].
Ghose, AK ;
Viswanadhan, VN ;
Wendoloski, JJ .
JOURNAL OF COMBINATORIAL CHEMISTRY, 1999, 1 (01) :55-68
[4]   Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings [J].
Lipinski, CA ;
Lombardo, F ;
Dominy, BW ;
Feeney, PJ .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) :3-25
[5]   A specific mechanism of nonspecific inhibition [J].
McGovern, SL ;
Helfand, BT ;
Feng, B ;
Shoichet, BK .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (20) :4265-4272
[6]   Kinase inhibitors: Not just for kinases anymore [J].
McGovern, SL ;
Shoichet, BK .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (08) :1478-1483
[7]   A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening [J].
McGovern, SL ;
Caselli, E ;
Grigorieff, N ;
Shoichet, BK .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (08) :1712-1722
[8]   Reactive compounds and in vitro false positives in HTS [J].
Rishton, GM .
DRUG DISCOVERY TODAY, 1997, 2 (09) :382-384
[9]   Development of a virtual screening method for identification of "frequent hitters" in compound libraries [J].
Roche, O ;
Schneider, P ;
Zuegge, J ;
Guba, W ;
Kansy, M ;
Alanine, A ;
Bleicher, K ;
Danel, F ;
Gutknecht, EM ;
Rogers-Evans, M ;
Neidhart, W ;
Stalder, H ;
Dillon, M ;
Sjögren, E ;
Fotouhi, N ;
Gillespie, P ;
Goodnow, R ;
Harris, W ;
Jones, P ;
Taniguchi, M ;
Tsujii, S ;
von der Saal, W ;
Zimmermann, G ;
Schneider, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (01) :137-142
[10]   Effect of detergent on "promiscuous" inhibitors [J].
Ryan, AJ ;
Gray, NM ;
Lowe, PN ;
Chung, CW .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (16) :3448-3451